Skip to main content
Log in

Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Ten children, 3 to 15 years of age with high risk primary brain tumors were treated with postradiation ‘eight in one’ chemotherapy; vincristine, lomustine, procarbazine, hydroxyurea, cisplatin, cytosine arabinoside, cyclophosphamide and methylprednisolone. The tumors comprised of three medulloblastomas, two primitive neuroectodermal tumors, one ependymoblastoma and four anaplastic ependymomas. Treatment involved surgery (two total resection, six subtotal and two biopsy only) followed by conventional radiotherapy (primary tumor: 50–54 Gy, whole brain: 30–45 Gy, and spinal axis: 25–36 Gy). Objective tumor response with radiotherapy was achieved in 7 of 9 patients (78%) (6/8 patients with residual tumor and one patient with complete resection but positive cerebrospinal fluid cytology). Complete response was attained in 4 of 9 patients (44%). ‘Eight in one’ chemotherapy was initiated four weeks after radiation and repeated at 4 weekly intervals for 5–8 courses. Postradiation ‘eight in one’ failed to show any additional effect on tumor responses. Median survival was 34 months (range 9–48 months) with five of ten patients alive: four in complete and one in partial remission. All the five survivors were among the patients who had achieved response to initial treatment. This result suggested that degree of response to initial treatment might determine subsequent outcome and thus the choice of modality for initial therapy might be important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bloom HJG, Glees J, Bell J: The treatment and long-term prognosis of children with intracranial tumors: A study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18: 723–745, 1990

    PubMed  Google Scholar 

  2. Li FP, Winston KR, Gimbrere K: Follow-up of children with brain tumors. Cancer 54: 135–138, 1984

    PubMed  Google Scholar 

  3. Cangir A, van Eys J, Berry DH, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 4: 253–261, 1978

    PubMed  Google Scholar 

  4. Crafts DC, Levin VA, Edwards MS: Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. J Neurosurg 49: 589–592, 1978

    PubMed  Google Scholar 

  5. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond D: The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 72: 572–582, 1990

    PubMed  Google Scholar 

  6. Tait DM, Thornton-Jones H, Bloom JL, Lemerle J, Morris J: Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP1). Eur J Cancer 26: 464–469, 1990

    PubMed  Google Scholar 

  7. Yung WA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42: 992–998, 1982

    PubMed  Google Scholar 

  8. Goldie JH: New thoughts in resistance to chemotherapy. Hosp Pract 18: 165–177, 1983

    Google Scholar 

  9. Hill BT, Baserga R: The cell cycle and its significance for cancer treatment. Cancer Treat Rev 2: 159–175, 1975

    PubMed  Google Scholar 

  10. Price LA, Hill BT: Safe and effective induction chemotherapy without cisplatin for squamous carcinoma of the head and neck. Impact on complete response rate and survival at five years following local therapy. Med Pediatr Oncol 10: 535–548, 1982

    PubMed  Google Scholar 

  11. Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, Heideman RL, Ruymann FB, Stuntz JT, Bleyer WA: Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5: 1221–1231, 1987

    PubMed  Google Scholar 

  12. Allen JC, Helson L, Jereb B: Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II Trial. Cancer 52: 2001–2006, 1983

    PubMed  Google Scholar 

  13. van Eys J, Cangir A, Coody D, Smith B: MOPP regimen as primary chemotherapy for brain tumors in infants. J NeuroOncol 3: 237–243, 1985

    PubMed  Google Scholar 

  14. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731, 1993

    PubMed  Google Scholar 

  15. Mosijczuk AD, Nigro MA, Thomas PRM, Burger PC, Krischer JP, Morantz RA, Kurdunowicz B, Mulne AF, Towbin RB, Freeman AI, Nigro ED, Friedman HS, Kun LE: Preradiation chemotherapy in advanced medulloblastoma. Cancer 72: 2755–2762, 1993

    PubMed  Google Scholar 

  16. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433–440, 1991

    PubMed  Google Scholar 

  17. Chang CH, Housepain EM, Herbert CJ: An operative staging system and a megavoltage radiation technique for cerebellar medulloblastoma. Radiology 93: 1351–1359, 1969

    PubMed  Google Scholar 

  18. Iacuone JJ, Steinherz LJ, Ablin AR: Modifications for toxicity. In: Ablin AR (ed) Supportive Care of Children with Cancer. Current therapy and guidelines from the Children's Cancer Group. The Johns Hopkins University Press Baltimore and London, 1993, 37–57

    Google Scholar 

  19. Rosen G, Capparas B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mekta B, Urban C: Preoperative chemotherapy for osteogenic sarcoma. Cancer 49: 1221–1230, 1982

    PubMed  Google Scholar 

  20. Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A, Lukens J, Siegel S: Analysis of prognostic factors in acute lymphoblastic leukemia. Med Ped Oncol 14: 124–134, 1986

    Google Scholar 

  21. Koscielniak E, Jurgens H, Winkler K, Burger D, Herbst M, Keim M, Bernhard G, Treuner J: Treatment of soft tissue sarcoma in childhood and adolescance: A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 70: 2557–2567, 1992

    PubMed  Google Scholar 

  22. Kim TH, Chin HW, Pollan S, Hazel JH, Webster JH: Radiotherapy of primary brain stem tumors. Int J Radiat Oncol Biol Phys 6: 51–57, 1980

    PubMed  Google Scholar 

  23. Kuhl J: Preliminary results of the German pilot trial HIT 88/89 in children and young adults with medulloblastoma. J Neuro-Oncol (Abstract) 12: 240, 1992

    Google Scholar 

  24. Rozental J, Trump D, Finlay J, Robins I, Steeves R, Langeland P, Schutta H: Pilot study of eight-drugs-in-one-day chemotherapy for high grade astrocytomas. J Neuro-Oncol (Abstract) 4: 115, 1986

    Google Scholar 

  25. Zeltzer P, Boyett J, Finlay J, Albright L, Wisoff J, Geyer R, McGuire P, Allen J, Rorke L, Stanley P, Stehbens J, Stevens K, Shurin S, Milstein J, Packer R, Bleyer A: Prognostic factors for survival in high risk PNETs in children: Report from CCG-921, Proc of ASCO (Abstract) 12: 415, 1993

    Google Scholar 

  26. Finlay J: An update on the brain tumor trials of the Children Cancer Study Group (CCSG). J Neuro-Oncol (Abstract) 12: 239, 1992

    Google Scholar 

  27. Rozental J, Robins I, Finlay J, Healey B, Levin AB, Steeves RA, Kohler PC, Schutta HS, Trump DL: 'Eight-drugs-inone-day: chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 63: 2475–2481, 1989

    PubMed  Google Scholar 

  28. Boiardi A, Silvani A, Milanesi I, Broggi G, Fariselli L: Efficacy of ‘8-days-in-one-day’ combination in treatment of recurrent GBM patients. J Neuro-Oncol 12: 153–158, 1992

    Google Scholar 

  29. Deen DF, Chiarodo A, Grimm EA, Fike JR, Israel MA, Kun LE, Levin VA, Marton LJ, Packer RJ, Pegg AE, Rosenblum ML, Suit HD, Walker MD, Wikstrand CJ, Wilson CB, Wong AJ, Yung WKA: Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. J Neuro-Oncol 16: 243–272, 1993

    Google Scholar 

  30. Jakacki R, Zeltzer P, Boyett J, Geyer J, Allen J, Finlay J, Albright A, Rorke L, Stanley P, Stevens K, Shurin S, McGuire P, Milstein J, Wisoff J, Stehbens J, Packer R, Bleyer A: Treatment and survival of pineoblastoma in childhood: Report of the Childrens Cancer Group Trial CCG-921. Proc ASCO (Abstract) 12: 415, 1993

    Google Scholar 

  31. Geyer JR, Pendergrass TW, Milstein JM, Bleyer WA: Eight drugs in one day chemotherapy in children with brain tumors. A critical toxicity appraisal. J Clin Oncol 6: 996–1000, 1988

    PubMed  Google Scholar 

  32. Kretschmar CS, Warren MP, Lavally BL, Dyer S, Tarbeil NJ: Ototoxicity of preradiation cisplatin for children with central nervous system tumors. J Clin Oncol 8: 1191–1198, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayan, I., Darendeliler, E., Kebudi, R. et al. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors. J Neuro-Oncol 26, 65–72 (1995). https://doi.org/10.1007/BF01054770

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01054770

Key words

Navigation